HIV Primary Infection: Clinical Trials

1 trial for HIV Primary Infection, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1

Follow HIV Primary Infection: new trials by email Literature Review of HIV Primary Infection trials Research Report on HIV Primary Infection

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bictegravir/FTC/TAF for the Treatment of Primary HIV Infection
50mg bictegravir/200mg emtricitabine/25mg tenofovir alafenamide - HIV Primary Infection
Phase 2UnknownAnna Cruceta662020-12-042021-07-19

Narrower conditions

Acquired Immunodeficiency Syndrome (1)

Broader conditions

Blood-Borne Infections (1)  ·  Communicable Diseases (1)  ·  Genital Diseases (1)  ·  HIV Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Infections (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Slow Virus Diseases (1)  ·  Urogenital Diseases (1)  ·  Virus Diseases (1)

Interventions

bictegravir (1)  ·  bictegravir, emtricitabine, tenofovir alafenamide, drug combination (1)

Sponsors

Anna Cruceta (1)

Countries

Spain (1)